NCT06028074
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06028074
Title Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Georgiamune Inc
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
The Angeles Clinic and Research Institute RECRUITING Los Angeles California 90025 United States Details
USC/Norris Comprehensive Cancer Center RECRUITING Los Angeles California 90033 United States Details
UCLA Hematology/Oncology RECRUITING Los Angeles California 90095 United States Details
UCSF Helen Diller Family Comprehensive Cancer Center RECRUITING San Francisco California 94143 United States Details
Florida Cancer Specialists RECRUITING Sarasota Florida 34232 United States Details
Norton Cancer Institute RECRUITING Louisville Kentucky 40202 United States Details
Rutgers Cancer Institute of NJ RECRUITING New Brunswick New Jersey 08903 United States Details
Tennessee Oncology, PLLC RECRUITING Nashville Tennessee 37203 United States Details
Texas Oncology - Baylor Sammons Cancer Center RECRUITING Dallas Texas 75246 United States Details
NEXT Oncology Dallas RECRUITING Irving Texas 75039 United States Details
Virginia Commonwealth University RECRUITING Richmond Virginia 23298 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field